CLOTRIMAZOLE IS APPLIED TOPICALLY TWO OR THREE TIMES DAILY FOR 2 TO 4 WEEKS AS A 1% CREAM, LOTION, SPRAY, OR SOLUTION IN THE TREATMENT OF FUNGAL SKIN INFECTIONS; A 1% POWDER MAY BE USED WITH THE CREAM OR SOLUTION AND HAS BEEN APPLIED TO PREVENT RE-INFECTION. THE 1% SOLUTION IS ALSO USED TOPICALLY FOR FUNGAL OTITIS EXTERNA. CLOTRIMAZOLE IS GIVEN AS PESSARIES IN DOSAGE REGIMENS OF 100 MG FOR 6 DAYS, 200 MG FOR 3 DAYS, OR A SINGLE DOSE OF 500 MG IN THE TREATMENT OF VULVOVAGINAL CANDIDIASIS; SIMILAR DOSES ARE GIVEN AS A 1, 2, OR 10% VAGINAL CREAM. IT MAY BE NECESSARY TO TREAT BALANITIS IN MALE PARTNERS CONCURRENTLY.
FOR THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS ONE 10-MG LOZENGE OF CLOTRIMAZOLE IS DISSOLVED IN THE MOUTH FIVE TIMES DAILY FOR 14 DAYS. FOR THE PROPHYLAXIS OF OROPHARYNGEAL CANDIDIASIS IN PATIENTS RECEIVING IMMUNOSUPPRESSANT THERAPY THE DOSE IS ONE 10-MG LOZENGE THREE TIMES DAILY FOR THE DURATION OF THE IMMUNOSUPPRESSANT TREATMENT. CLOTRIMAZOLE HAS ALSO BEEN GIVEN BY MOUTH BUT HAS NOW BEEN LARGELY SUPERSEDED BY OTHER AZOLE DRUGS.